PG
ZBH icon

Pendal Group’s Zimmer Biomet ZBH Stock Holding History

Pendal Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,736
Closed -$201K – 508
2020
Q2 		$201K Buy
+1,736
New +$200K ﹤0.01% 425
2017
Q4 		– Sell
-4,553
Closed -$518K – 495
2017
Q3 		$518K Sell
4,553
-96
-2% -$11.1K 0.01% 372
2017
Q2 		$580K Buy
+4,649
New +$551K 0.01% 351

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pendal Group's ZBH Position: Q3 2020 in Review

Pendal Group sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 1,736 shares — an estimated $201K sold.

Pendal Group first reported a position in ZBH in Q2 2017 and held it in 3 quarters. The position peaked at $580K in Q2 2017. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

  • Pendal Group reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
  • Pendal Group sold 1,736 Zimmer Biomet shares in Q3 2020, an estimated $201K.
  • Pendal Group first reported a position in Zimmer Biomet in Q2 2017 and held it in 3 quarters.
  • Pendal Group's Zimmer Biomet position peaked at $580K in Q2 2017.
  • 930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Pendal Group's 13F filing for Q3 2020, filed 2 Nov 2020.